← back to database
Codon Capital invests in biotechnology startups to translate scientific breakthroughs into real products. It focuses on therapeutics and synthetic biology, aiming to back teams tackling hard technical, definable achievements. The firm provides early-stage funding and strategic guidance to founders, leveraging its domain expertise for biotech translational hurdles. As a San Francisco-based venture capital firm, it targets opportunities in healthcare and sustainable agriculture. Its approach supports portfolio companies through multiple rounds and aligns with long-term biotech product development.
Investment focus
Investment style
Specialist